Clinically important cancer types with infrequent and often weak GPX2 staining included sarcomas, lymphomas, high-grade serous ovarian carcinomas, prostatic adenocarcinomas, melanomas, mesotheliomas, and renal cell carcinomas. Here, GPX2 is linked to renal cell carcinoma.